Skip to content
CancerIndex

Publication

The impact of effective dose to the immune cells on survival in breast cancer patients.

Stefanie A de Boer, Daan S Spoor, John H Maduro, Pieter R A J Deseyne, Christina T Muijs, Nanna M Sijtsema, Suzanne P M de Vette, Lisanne V van Dijk, Ewoud Schuit, Johannes A Langendijk, Anne P G Crijns

Clinical and translational radiation oncologyNov 1, 2026PMID 42662902doi:10.1016/j.ctro.2026.101251 PMC13521130Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 11, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260911-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

PURPOSE: In patients with thoracic cancers such as lung and esophageal cancer, higher radiation exposure to immune cells is associated with worse survival outcomes. This study aims to determine whether a similar association between Effective Dose to the Immune Cells (EDIC) and BC-specific survival…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.